Page et al. (2022) identified HMGN1, a chromosome 21-encoded gene, as a significant enhancer of CRLF2-mediated leukemic transformation, showing a chromosome 21 dosage effect in DS-ALL [69]. Here, CRLF2 is linked to acute lymphoblastic leukemia.